InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

BIOMERICA INC

BMRA Clue Score31
United States Fiscal year ends May CIK 0000073290
$1.84 -2.90% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.84 −70.59% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue5.8Operating income−1.0Net income−0.9EPS, diluted−0.11Fiscal year 2018Revenue5.6 −3.9%Operating income−1.5Net income−1.5EPS, diluted−0.17Fiscal year 2019Revenue5.2 −6.5%Operating income−2.4Net income−2.4EPS, diluted−0.26Fiscal year 2020Revenue6.7 +28.7%Operating income−2.7Net income−2.7EPS, diluted−0.26Fiscal year 2021Revenue7.2 +7.6%Operating income−7.5Net income−7.4EPS, diluted−0.62Fiscal year 2022Revenue18.9 +162.1%Operating income−4.5Net income−4.5EPS, diluted−0.36Fiscal year 2023Revenue5.3 −71.7%Operating income−7.2Net income−7.1EPS, diluted−0.50Fiscal year 2024Revenue5.4 +1.4%Operating income−6.4Net income−6.0EPS, diluted−2.84Fiscal year 2025Revenue5.3 −1.9%Operating income−5.1Net income−5.0EPS, diluted−2.16Fiscal year 2026Revenue4.5 −16.2%Operating income−5.3Net income−3.8EPS, diluted−1.30
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 5.8 5.6 5.2 6.7 7.2 18.9 5.3 5.4 5.3 4.5
Growth −3.9% −6.5% +28.7% +7.6% +162.1% −71.7% +1.4% −1.9% −16.2%
Operating income −1.0 −1.5 −2.4 −2.7 −7.5 −4.5 −7.2 −6.4 −5.1 −5.3
Net income −0.9 −1.5 −2.4 −2.7 −7.4 −4.5 −7.1 −6.0 −5.0 −3.8
Growth
EPS, diluted −0.11 −0.17 −0.26 −0.26 −0.62 −0.36 −0.50 −2.84 −2.16 −1.30

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin34.9%Operating margin−16.5%Net margin−15.7%Free cash flow margin−14.1%Fiscal year 2018Gross margin31.5%Operating margin−26.6%Net margin−26.3%Free cash flow margin−23.4%Fiscal year 2019Gross margin24.8%Operating margin−46.4%Net margin−46.0%Free cash flow margin−45.1%Fiscal year 2020Gross margin26.0%Operating margin−41.0%Net margin−40.0%Free cash flow margin−64.7%Fiscal year 2021Gross margin5.1%Operating margin−104.2%Net margin−103.4%Free cash flow margin−74.8%Fiscal year 2022Gross margin15.8%Operating margin−24.0%Net margin−24.0%Free cash flow margin−2.8%Fiscal year 2023Gross margin8.4%Operating margin−135.3%Net margin−133.7%Free cash flow margin−103.7%Fiscal year 2024Gross margin11.3%Operating margin−117.6%Net margin−110.4%Free cash flow margin−99.9%Fiscal year 2025Gross margin9.4%Operating margin−96.7%Net margin−93.6%Fiscal year 2026Gross margin8.1%Operating margin−119.5%Net margin−84.8%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin 34.9% 31.5% 24.8% 26.0% 5.1% 15.8% 8.4% 11.3% 9.4% 8.1%
Operating margin −16.5% −26.6% −46.4% −41.0% −104.2% −24.0% −135.3% −117.6% −96.7% −119.5%
Net margin −15.7% −26.3% −46.0% −40.0% −103.4% −24.0% −133.7% −110.4% −93.6% −84.8%
Free cash flow margin −14.1% −23.4% −45.1% −64.7% −74.8% −2.8% −103.7% −99.9% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−0.7Capital expenditure−0.1Free cash flow−0.8Fiscal year 2018Operating cash flow−1.2Capital expenditure−0.1Free cash flow−1.3Fiscal year 2019Operating cash flow−2.2Capital expenditure−0.1Free cash flow−2.3Fiscal year 2020Operating cash flow−4.3Capital expenditure−0.0Free cash flow−4.3Fiscal year 2021Operating cash flow−5.3Capital expenditure−0.1Free cash flow−5.4Fiscal year 2022Operating cash flow−0.5Capital expenditure−0.1Free cash flow−0.5Fiscal year 2023Operating cash flow−5.5Capital expenditure−0.1Free cash flow−5.5Fiscal year 2024Operating cash flow−5.4Capital expenditure−0.1Free cash flow−5.4Fiscal year 2025Operating cash flow−3.8Fiscal year 2026Operating cash flow−3.4
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −0.7 −1.2 −2.2 −4.3 −5.3 −0.5 −5.5 −5.4 −3.8 −3.4
Capital expenditure −0.1 −0.1 −0.1 −0.0 −0.1 −0.1 −0.1 −0.1 n/a n/a
Free cash flow −0.8 −1.3 −2.3 −4.3 −5.4 −0.5 −5.5 −5.4 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash1.2Shareholders’ equity4.5Fiscal year 2018Cash1.2Shareholders’ equity4.3Fiscal year 2019Cash0.7Shareholders’ equity4.0Fiscal year 2020Cash8.6Shareholders’ equity14.2Fiscal year 2021Cash4.2Shareholders’ equity9.2Fiscal year 2022Cash5.9Shareholders’ equity8.3Fiscal year 2023Cash9.7Shareholders’ equity11.7Fiscal year 2024Cash4.2Shareholders’ equity6.6Fiscal year 2025Cash2.4Shareholders’ equity4.1Fiscal year 2026Cash1.3Shareholders’ equity2.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 1.2 1.2 0.7 8.6 4.2 5.9 9.7 4.2 2.4 1.3
Shareholders’ equity 4.5 4.3 4.0 14.2 9.2 8.3 11.7 6.6 4.1 2.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending May, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 May 2017 FY2018 31 May 2018 FY2019 31 May 2019 FY2020 31 May 2020 FY2021 31 May 2021 FY2022 31 May 2022 FY2023 31 May 2023 FY2024† 31 May 2024 FY2025 31 May 2025 FY2026 31 May 2026
Revenue and profit
5.8 5.6 5.2 6.7 7.2 18.9 5.3 5.4 5.3 4.5
Growth −3.9% −6.5% +28.7% +7.6% +162.1% −71.7% +1.4% −1.9% −16.2%
3.8 3.8 3.9 5.0 6.8 15.9 4.9 4.8 4.8 4.1
2.0 1.8 1.3 1.7 0.4 3.0 0.4 0.6 0.5 0.4
Growth −13.2% −26.4% +34.5% −78.9% +712.8% −85.0% +37.0% −18.5% −27.3%
1.1 1.4 1.7 1.9 2.2 1.8 1.6 1.5 1.0 0.8
1.8 1.8 2.0 2.5 5.7 5.7 6.1 5.5 4.6 4.9
−1.0 −1.5 −2.4 −2.7 −7.5 −4.5 −7.2 −6.4 −5.1 −5.3
Growth
−0.9 −1.4 −2.4 −2.7 −7.4 −4.5 −7.1 −5.9 −5.0 −3.8
n/a 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
−0.9 −1.5 −2.4 −2.7 −7.4 −4.5 −7.1 −6.0 −5.0 −3.8
Growth
Per share
−0.11 −0.17 −0.26 −0.26 −0.62 −0.36 −0.50 −2.84 −2.16 −1.30
−0.11 −0.17 −0.26 −0.26 −0.62 −0.36 −0.50 −2.84 −2.16 −1.30
Growth
8.3 8.6 9.2 10.2 11.9 12.7 14.2 2.1 2.3 2.9
8.3 8.6 9.2 10.2 11.9 12.7 14.2 2.1 2.3 2.9
Growth +2.9% +7.5% +10.4% +17.3% +6.2% +11.7% −85.1% +9.2% +26.9%

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 9.2% a year over five years.
  • Operating margin is down 15.3 points on five years ago, at -119.5%.
  • A net loss in 10 of 10 years on file.